Showing 63,301 - 63,320 results of 102,609 for search '(( a web decrease ) OR ( 5 ((step decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.63s Refine Results
  1. 63301

    Suppressive effect of arginine and sodium fluoride on enamel calcium loss and antibiofilm activity on mature oral microcosm biofilms by Daniela Alejandra Cusicanqui Méndez (5560673)

    Published 2025
    “…While all treatments resulted in a reduction of α-EPS, 8% arginine showed the most pronounced effect, being the only treatment to decrease β-EPS compared to the control. …”
  2. 63302

    Climate change has likely already affected global food production by Deepak K. Ray (423970)

    Published 2019
    “…However, current impacts on a diversity of crops subnationally and implications for food security remains unclear. …”
  3. 63303

    Signaling pathway analysis following MCSF and RANKL treatment. by Muzaffer Cicek (227597)

    Published 2011
    “…<p><b>A</b>. Osteoclast precursors at day 3 and mature osteoclasts at day 4 were serum-starved and treated with MCSF, RANKL or MCSF+RANKL as indicated for five minutes. …”
  4. 63304

    Data_Sheet_1_Bacterial Profiling and Dynamic Succession Analysis of Phlebopus portentosus Casing Soil Using MiSeq Sequencing.docx by Rui-Heng Yang (3182814)

    Published 2019
    “…To date, P. portentosus is the only species in the order Boletales that can be successfully cultivated worldwide. The use of a casing layer or casing soil overlaying the substrate is a crucial step in the production of this mushroom. …”
  5. 63305

    Table_1_Muscle Loss During Androgen Deprivation Therapy Is Associated With Higher Risk of Non-Cancer Mortality in High-Risk Prostate Cancer.docx by Pai-Kai Chiang (11448058)

    Published 2021
    “…Body mass index changes were highly and weakly correlated with changes in TATI and SMI, respectively (Spearman ρ for TATI, 0.78, p<0.001; ρ for SMI, 0.27, p=0.003). As a continuous variable, each 1% decrease in SMI was independently associated with a 9% increase in the risk of non-cancer mortality (hazard ratio: 1.09; p=0.007). …”
  6. 63306

    Termites' effects on arboreal predators. by Robert M. Pringle (248396)

    Published 2010
    “…Experimental prey supplementation at 30 m essentially equalized mean occupation rates at 10 m and 30 m (red markers; time × proximity interaction: <i>F</i><sub>1,33</sub> = 7.5, <i>p</i><0.01; <a href="http://www.plosbiology.org/article/info:doi/10.1371/journal.pbio.1000377#pbio.1000377.s008" target="_blank">Table S3</a>). …”
  7. 63307
  8. 63308

    CMV DNAemia specific protein signatures exist pre-CMV DNAemia timepoint and post-CMV. by Tara K. Sigdel (9386207)

    Published 2023
    “…This analysis resulted in significant changes in 16 proteins, with an increase in their level with CMV infection (n = 11) and a decrease in their level with CMV DNAemia (n = 5). …”
  9. 63309

    Image_3_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.jpeg by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  10. 63310

    Image3_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.TIFF by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  11. 63311

    Activity of the small molecule PLK1, 2, and 3 inhibitor BI 2536 in preclinical models of MM in the absence of the bone microenvironment. by Douglas W. McMillin (348456)

    Published 2013
    “…(G–I) Animal studies performed in a subcutaneous model of MM (n = 9, control n = 8, treated) showed significant suppression of tumor burden (p = 0.0005; panel G), prolongation of survival (p<0.0001; Kaplan-Meier & log rank test; panel H) and no significant decrease in average body weight (panel I), consistent with lack of major toxicity. …”
  12. 63312

    Image1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.tif by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  13. 63313

    DataSheet1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.pdf by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  14. 63314

    Image1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.TIFF by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  15. 63315

    Table1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.DOCX by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  16. 63316

    Table_1_The association of cognitive function and its changes with all-cause mortality among community-dwelling older adults.DOCX by Shangjie Li (18809476)

    Published 2024
    “…</p>Results<p>Participants’ median age was 70 years, with 39% men. Over a median 3.08-year follow-up, 525 died. Mortality risk increased by 6% per MMSE score decrease (adjusted HR = 1.06, 95%CI: 1.05–1.08). …”
  17. 63317

    DataSheet1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.pdf by Yilin Chen (678552)

    Published 2022
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  18. 63318

    Image_1_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.tif by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”
  19. 63319

    DataSheet1_Impact of the Pilot Volume-Based Drug Purchasing Policy in China: Interrupted Time-Series Analysis with Controls.pdf by Yilin Chen (678552)

    Published 2021
    “…Overall, in pilot cities, there was a 35% (95%-CI: 28–41%, p < 0.001) decrease in the purchase spending for all drugs in the first post-policy month, from 8.1 billion CNY estimated in the absence of VBP down to 5.3 billion CNY; in control cities, the change was negligible. …”
  20. 63320

    Image_6_Ruxolitinib does not completely abrogate the functional capabilities of TLR4/9 ligand-activated NK cells.tif by Carmen Mestre-Durán (7121327)

    Published 2023
    “…Only the highest doses of ruxolitinib led to a decrease in the pro-inflammatory cytokines tumor necrosis factor α, interferon-γ, interleukin-6, and interleukin-1β. …”